RNA Methyltransferase Inhibition Validates Epitranscriptomic Regulation as a Novel Approach in the Treatment of Solid Tumors

• Positioning RNA epitranscriptomics as a novel small molecule modality for cancer therapy
• Exploring methyltransferase inhibition as a means to alter tumour cell phenotype and limit cancer adaptability
• Mechanisms underlying the pharmacology of METTL3 inhibition across tumor types

Speakers:

Andrea Casazza

Head of Cancer Biology

EPICS Therapeutics